Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Aylesbury and Cervitula Spatulas

Aylesbury and Cervitula Spatulas Acta Cytologica A Comparative Study to Assess the Adequacy of Cervical Smears Jacobus M. du Plessis, M.B.,Ch.B., Albrecht E. Schaetzing, M.D., F.C.O.G.(S.A.), F.R.C.O.G., Ph.D.(Stell), Peter A. B. Wrantz, M.B.,Ch.B., M.Med.(O&G), M.Med.(Path.), F.C.O.G.(S.A.), F.R.C.O.G., M.I.A.C., and Mercia Louw, M.B.,Ch.B., M.Med.(Path.) OBJECTIVE: To assess whether the Aylesbury (Pharma- tification of endocervical cells in obstetric patients ceutical Enterprises Ltd., (P = .0008). When combin- Pinelands, Capetown, South ing the obstetric and gyne- Africa) or Cervitula spatula cology groups, the Cervitula The Cervitula was more effective in (Harwill Medical, Cape- was also better in obtaining obtaining endocervical cells when town, South Africa) is more endocervical cells, but this effective for adequate cervical did not reach statistical sig- compared to the Aylesbury spatula. smears in obstetric and gyne- nificance (P = .016). cology patients. CONCLUSION: Pap smear STUDY DESIGN: The sampling with the Cervitula Cervitula spatula was compared with the Aylesbury reduces the number of cases without endocervical cells, spatula by taking a total of 160 smears, which were ex- which would constitute an inadequate smear, requiring amined cytologically. This consisted of 40 obstetric and unnecessary recall of patients for repeat smears. (Acta 40 gynecology patients. The sequence in which the spat- Cytol 2001;45:675–678) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Cytologica Karger

Loading next page...
 
/lp/karger/aylesbury-and-cervitula-spatulas-ErfrSxN6Zg

References (11)

Publisher
Karger
Copyright
© 2011 S. Karger AG, Basel
ISSN
0001-5547
eISSN
1938-2650
DOI
10.1159/000328286
Publisher site
See Article on Publisher Site

Abstract

Acta Cytologica A Comparative Study to Assess the Adequacy of Cervical Smears Jacobus M. du Plessis, M.B.,Ch.B., Albrecht E. Schaetzing, M.D., F.C.O.G.(S.A.), F.R.C.O.G., Ph.D.(Stell), Peter A. B. Wrantz, M.B.,Ch.B., M.Med.(O&G), M.Med.(Path.), F.C.O.G.(S.A.), F.R.C.O.G., M.I.A.C., and Mercia Louw, M.B.,Ch.B., M.Med.(Path.) OBJECTIVE: To assess whether the Aylesbury (Pharma- tification of endocervical cells in obstetric patients ceutical Enterprises Ltd., (P = .0008). When combin- Pinelands, Capetown, South ing the obstetric and gyne- Africa) or Cervitula spatula cology groups, the Cervitula The Cervitula was more effective in (Harwill Medical, Cape- was also better in obtaining obtaining endocervical cells when town, South Africa) is more endocervical cells, but this effective for adequate cervical did not reach statistical sig- compared to the Aylesbury spatula. smears in obstetric and gyne- nificance (P = .016). cology patients. CONCLUSION: Pap smear STUDY DESIGN: The sampling with the Cervitula Cervitula spatula was compared with the Aylesbury reduces the number of cases without endocervical cells, spatula by taking a total of 160 smears, which were ex- which would constitute an inadequate smear, requiring amined cytologically. This consisted of 40 obstetric and unnecessary recall of patients for repeat smears. (Acta 40 gynecology patients. The sequence in which the spat- Cytol 2001;45:675–678)

Journal

Acta CytologicaKarger

Published: Jan 1, 2011

There are no references for this article.